Last reviewed · How we verify
NCT06587087
A Proof of Concept (PoC), Randomized, Controlled Study to Validate the Algorithm and Evaluate the Accuracy, Safety and Pain Level of the Smartest-AE in Comparison to Self-measure Blood Glucose Levels
NA trial testing Smartest-AE: The lancet that will be used will be the Vitrex Soft Lite lll 28G. in Diabetes Mellitus in 300 participants. Not yet recruiting.
31 January 2025
Quick facts
| Lead sponsor | Smartest Technologies |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 300 |
| Start date | 20 September 2024 |
| Primary completion | 31 January 2025 |
| Estimated completion | 15 February 2025 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Smartest-AE: The lancet that will be used will be the Vitrex Soft Lite lll 28G.
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
- Gestational Diabetes Mellitus (GDM) — all drugs for Gestational Diabetes Mellitus (GDM) →
- Pre Diabetes — all drugs for Pre Diabetes →
Sponsor
Smartest Technologies
Who can join
Adults 18 to 80, any sex, with Diabetes Mellitus or Gestational Diabetes Mellitus (GDM). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is conducted in Israel so plain language for the study is exist in Hebrew only
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06587087
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06587087 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Smartest Technologies
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06587087.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing